That long tail is why one missed dose is rarely dramatic, why side effects fade gradually rather than overnight, and why appetite returns in weeks, not days, after stopping
The SUSTAIN 29,30,31,32,33,34,35 and SCALE studies 10,11,12,13,14,15 have shown robust efficacy in lowering blood glucose levels in diabetic patients and inducing weight loss in obese patients over clinical trial periods ranging from 30 to 104 weeks
This longer duration of action produces more sustained GH and IGF-1 elevation between doses
*Aumento o mejora considerada cuando se present un incremento igual o mayor a 0.5 kg
The Bridge program rules say that people can use the drugs to maintain weight loss. Thats because doctors have found that if people successfully lose weight using GLP-1 medications, then stop taking the drugs, they typically gain the weight back
and to reduce kidney disease risk in people with type 2 diabetes and chronic kidney disease